Innovaccer kicked off a shopping spree instead of chasing an IPO, and virtual specialty care platform Story Health just became the latest startup to get crossed off the acquisition list.
Innovaccer’s been busy. It spent years building the technical infrastructure to make healthcare actually work, and it’s now acquiring the pieces to show what’s possible with that foundation.
- That includes picking up Humbi AI (actuarial intelligence), Cured (healthcare marketing/CRM), and Pharmacy Quality Solutions (pharma-payor performance tech).
- It also means equipping more healthcare orgs with its new solutions like Gravity (connects nearly every data input into a single source of truth to scale AI adoption) and Comet (an AI-powered access center with a name so good that Epic had to steal it).
Here come the agents. Story’s cardiovascular health platform is designed to shift care from episodic visits to continuous management that can move the needle on value-based outcomes.
- The platform combines AI-driven clinical pathways, advanced medication workflows, and human-led coaching to deliver industry-leading results across heart failure and other chronic conditions.
- Innovaccer will be using Story as its first scaffolding to “pioneer agentic care augmentation,” where EHR-integrated AI agents will help specialty care teams with non-clinical tasks and engage patients between visits.
There’s more on the way. Innovaccer recently revealed that it has “two to three additional acquisitions planned in the coming months,” and that hospital administration and revenue cycle management are both major focus areas.
- Although Hinge and Omada helped crack open the digital health IPO window, Innovaccer’s business is quickly evolving, and it still has the freedom to make longer-term plays in the private markets.
- Answering to public shareholders wouldn’t exactly offer Innovaccer any more freedom, and it’s using its unrestricted range of motion to take advantage of private markets that “have never had the kind of depth they have today.”
The Takeaway
We love to see a good crossover story. Innovaccer didn’t just acquire Story to improve outcomes for its patients, it acquired it to scale those outcomes to patients everywhere – and we shouldn’t have to wait long to see another chapter that takes the same playbook to a new specialty.
